-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Elite Pharmaceuticals Inc /Nv/ quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q2 2010 to Q2 2024.
- Elite Pharmaceuticals Inc /Nv/ Net Cash Provided by (Used in) Operating Activities for the quarter ending June 30, 2024 was $3.14M.
- Elite Pharmaceuticals Inc /Nv/ annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$3.28M, a 198% decline from 2022.
- Elite Pharmaceuticals Inc /Nv/ annual Net Cash Provided by (Used in) Operating Activities for 2022 was $3.34M, a 48.7% decline from 2021.
- Elite Pharmaceuticals Inc /Nv/ annual Net Cash Provided by (Used in) Operating Activities for 2021 was $6.51M, a 104% increase from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)